Tofogliflozin-d5

• Catalog No.: T528752
• M. F.: C22H26O6
• M. W.: 386.43824

SYNONYMS

• IUPAC name: (1S,3'R,4'S,5'S,6'R)-6-{[4-(^2H₅)ethylphenyl]methyl}-6'-(hydroxymethyl)-3H-spiro[2-benzofuran-1,2'-oxane]-3',4',5'-triol
• IUPAC Traditional name: (1S,3'R,4'S,5'S,6'R)-6-{[4-(^2H₅)ethylphenyl]methyl}-6'-(hydroxymethyl)-3H-spiro[2-benzofuran-1,2'-oxane]-3',4',5'-triol
• Synonyms: CSG 452-d5; (1S,3'R,4'S,5'S,6'R)-6-[[4-(Ethyl-d5)phenyl]methyl]-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro[isobenzofuran-1(3H),2'-[2H]pyran]-3',4',5'-triol

DETAILS

Description (English)

A labelled novel, potent, and highly selective SGLT2 inhibitor that has been shown to improve glycemic control in diabetic mice and rats.